(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INBRIJA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

INBRIJA

ST13

US500000087980717

Class

5, 10

Filing

87980717

Registration

5875276

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

55

Latest update

12/24/2025

Classification

Registered

Trademark type

Combined

Nice classes

5, 10

Filing date

05/26/2017

Registration date

10/01/2019

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/23/2025

Last transaction

12/24/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/25/2019

First use in commerce

02/25/2019

Drawing code

3

Owner type

16

Owner location

RALEIGH, NC

Examiner

GREENE,JOSEPH A

Current location

Historical data usage

Mark description

The mark consists of the stylized wording "INBRIJA" next to a miscellaneous polygonal shape that resembles a curving triangle.

Holders and representatives

Holders

MERZ PHARMACEUTICALS, LLC
ACORDA THERAPEUTICS, INC.

Representatives

Joseph C. Guagliardo Dentons US LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical productspharmaceutical and biological preparations used in the treatment of diseasesdisorders or conditions of the nervous system

Class 10

medical devicesdrug delivery system that facilitates the delivery of pharmaceutical and biological preparations used in the treatment of diseasesdisorders or conditions of the nervous system

Publications

History of USPTO decisions and trademark events.

55 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/23/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/23/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/15/2025

E815

TEAS SECTION 8 & 15 RECEIVED

09/11/2025

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/15/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/01/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

12/02/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/02/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/02/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/02/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

12/02/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

10/01/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/27/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/26/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/19/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/19/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/08/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/24/2019

GNRT

NON-FINAL ACTION E-MAILED

07/24/2019

CNRT

SU - NON-FINAL ACTION - WRITTEN

07/24/2019

DOCK

ASSIGNED TO EXAMINER

05/17/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/01/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/30/2019

DPCC

DIVISIONAL PROCESSING COMPLETE

04/30/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/26/2019

IUAF

USE AMENDMENT FILED

04/04/2019

DRRR

DIVISIONAL REQUEST RECEIVED

04/04/2019

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

04/04/2019

EISU

TEAS STATEMENT OF USE RECEIVED

04/04/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/06/2018

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/04/2018

EX2G

SOU EXTENSION 2 GRANTED

12/04/2018

EXT2

SOU EXTENSION 2 FILED

12/04/2018

EEXT

SOU TEAS EXTENSION RECEIVED

12/04/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/06/2018

EX1G

SOU EXTENSION 1 GRANTED

06/04/2018

EXT1

SOU EXTENSION 1 FILED

06/04/2018

EEXT

SOU TEAS EXTENSION RECEIVED

06/04/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/19/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/24/2017

PUBO

PUBLISHED FOR OPPOSITION

10/24/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/04/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/13/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/12/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/12/2017

ALIE

ASSIGNED TO LIE

09/10/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/28/2017

GEAN

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

08/14/2017

GEAP

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

08/14/2017

EPEN

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

08/14/2017

CPEA

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

08/14/2017

DOCK

ASSIGNED TO EXAMINER

07/28/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

06/03/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/02/2017

NWAP

NEW APPLICATION ENTERED

05/30/2017

Continuous trademark protection

Get notified about every new filing that threatens INBRIJA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.